About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Effect of IMT in Patients After Acute Exacerbations of COPD

Effect of IMT in Patients After Acute Exacerbations of COPD

NCT07213128·12 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Marine Van Hollebeke, PhD
CONTACT
0032498606820 marine.vanhollebeke@kuleuven.be
Daniel Langer, PhD
CONTACT
0032 16 37 64 97 daniel.langer@kuleuven.be

Lead

KU Leuven

With

Hopitaux Iris Sud
Centre Hospitalier Universitaire Saint Pierre
Onze Lieve Vrouw Hospital
AZ Delta
University Hospital, Antwerp
Algemeen Ziekenhuis Maria Middelares
Grand Hôpital de Charleroi
Centre Hospitalier Universitaire UCLouvain Namur
Centre Hospitalier Universitaire de Liege
General Hospital Groeninge
University Hospital, Ghent

Age

35–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients admitted to the hospital ≥3 days for AECOPD
Read and speak French, Dutch or English
Age ≥ 35 years
Able to provide informed consent
Possessing a smartphone, compatible with the tele-monitoring app and able to perform video meetings.

You may not be if

Patients already performing IMT at time of inclusion
Patients with estimated \<90 days life expectancy
Non-COPD pulmonary disease as primary diagnosis
Active malignancy
Inability to perform IMT or response to questionnaires (e.g., neurological/cognitive impairment)
Acute instable cardiac arrythmia or ischemia
Acute pneumothorax
Planned lung volume reduction procedure \<180days
Waitlisted for lung transplantation
Patients admitted to an in-hospital rehabilitation ward
Patients included in other interventional trial related to COPD that would interfere with our trial outcomes.

The record

StatusRecruiting

PhaseNo phase

Taking part358

StartedJan 2026

UpdatedMay 28, 2026

Conditions

Chronic Obstructive Pulmonary Diseases COPD Symptom Exacerbation

Where12

AZORG
Aalst, Belgium
Campus Joseph Bracops, Hôpitaux Iris Sud
Anderlecht, Belgium
Centre Hospitalier Universitaire Saint-Pierre
Brussels, Belgium